Table 2.
Oncologic outcomes.
| N | % | |
|---|---|---|
| Locoregional recurrence | 73 a | 12 |
| Skin/chest wall | 27 | 4.4 |
| Nipple-areola complex | 7 | 1.9 b |
| Regional lymph nodes | 45 | 7.4 |
| Distant metastasis | 99 | 16.3 |
| Any first recurrence | 138 | 22.7 |
| Death | 57 | 9.4 |
| 5-y locoregional recurrence-free survival | 87.6 | |
| 5-y disease-free survival | 77.5 | |
| 5-y distant metastasis-free survival | 83.6 | |
| 5-y overall survival | 92.3 |
a
Including 5 cases of concurrent local and regional recurrence without distant metastasis, and 18 cases of concurrent local and/or regional recurrence with distant metastasis as the first event.
b
Calculated in 370 cases of nipple-sparing mastectomy.